Benslimane-Ahmim, Zahia <br/><br/>
Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularization.  [electronic resource] 

 -  Cancer letters  06 2017 
 - 11-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2017.02.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Chemokine CXCL12--physiology<br/>Fibroblast Growth Factor 2--pharmacology<br/>Humans<br/>Mice<br/>Neoplasms--blood supply<br/>Neovascularization, Pathologic--chemically induced<br/>Osteoprotegerin--pharmacology<br/>Receptors, CXCR4--physiology<br/>Xenograft Model Antitumor Assays